Cargando…
Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
Autores principales: | Issa, Amalia M., Thorogood, Adrian, Joly, Yann, Knoppers, Bartha M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752286/ https://www.ncbi.nlm.nih.gov/pubmed/29988078 http://dx.doi.org/10.1038/s41436-018-0099-0 |
Ejemplares similares
-
Correction to: Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
por: Issa, Amalia M., et al.
Publicado: (2018) -
Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
por: Lemery, Steven, et al.
Publicado: (2022) -
International ethics harmonization and the global alliance for genomics and health
por: Knoppers, Bartha M
Publicado: (2014) -
An implementation framework for the feedback of individual research results and incidental findings in research
por: Thorogood, Adrian, et al.
Publicado: (2014) -
Computational tools for genomic data de-identification: facilitating data protection law compliance
por: Bernier, Alexander, et al.
Publicado: (2021)